Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Innovation and Evidence for Achieving TB Elimination in the Asia-Pacific Region
| Innovation and Evidence for Achieving TB Elimination in the Asia-Pacific Region |
| Autore | DuCros Philipp |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (238 p.) |
| Soggetto topico |
Humanities
Social interaction |
| Soggetto non controllato |
pediatric TB
verbal screening contact tracing resources sputum health promotion operational research indigenous population multidrug-resistant tuberculosis household contact screening TB diagnosis yield operations research contacts contact investigation MDR-TB public-private mix model public-private partnership missing cases SORT IT TB diagnostics laboratory methods case detection Xpert Ultra STR Bangladesh regimen tuberculosis post-tuberculosis morbidity and mortality TB preventive therapy latent TB infection Asia Pacific rifapentine-isoniazid incidence household contacts tracing End TB sustainable development goals South-East Asia Western Pacific Region national TB program socio-economic determinants diabetes mellitus TB-DM adverse drug reactions unfavourable outcome lymph node TB bone TB TB elimination extrapulmonary tuberculosis private sector intermediary agency referral notification Viet Nam active case finding community outreach Indonesia key population innovation TB REACH community health workers mobile X-ray screening TB chest X-ray active TB case-finding diagnostic algorithm |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557609703321 |
DuCros Philipp
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Natural Resistance to and Host-Directed Prevention of Tuberculosis
| Natural Resistance to and Host-Directed Prevention of Tuberculosis |
| Autore | Wilkinson Robert |
| Pubbl/distr/stampa | Frontiers Media SA, 2020 |
| Descrizione fisica | 1 electronic resource (161 p.) |
| Soggetto topico |
Medicine
Immunology |
| Soggetto non controllato |
Tuberculosis
TB LTBI Host-directed prevention |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557217803321 |
|
Wilkinson Robert
|
||
| Frontiers Media SA, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Tuberculosis Drug Discovery and Development 2019
| Tuberculosis Drug Discovery and Development 2019 |
| Autore | Riccardi Giovanna |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (296 p.) |
| Soggetto topico |
Research & information: general
Biology, life sciences |
| Soggetto non controllato |
mycobacteria
tuberculosis multi-drug resistance drug discovery promiscuous targets Mycobacterium tuberculosis rifampin isoniazid mechanisms of resistance mutations granulomas caseum cell envelope dormancy delpazolid macozinone DprE1 inhibitor clinical studies discovery mode of action drug resistance toxicity target energy metabolism electron transport chain oxidative phosphorylation bedaquiline Q203 MID3 pharmacokinetics pharmacodynamics drug-drug interactions in vitro in vivo drug development tuberculosis treatment biomarkers drug combination clinical trial BCG tuberculosis vaccines TBVI EDCTP IAVI CTVD host-directed therapy anti-virulence compounds TB post-treatment sequelae surgery pulmonary rehabilitation Carlo Forlanini artificial pneumothorax structure-based drug design target-based drug design PknB PknG DNA gyrase antibiotic mycobacterium genomics transcriptomics proteomics metabolomics lipidomics target identification mechanism of action antimicrobial drug resistance (AMR) target-based screening phenotypic screening antituberculosis agents antimycobacterial anti-TB drug pipeline privileged targets lead generation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557627203321 |
|
Riccardi Giovanna
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||